Results 201 to 210 of about 2,435 (258)
Some of the next articles are maybe not open access.
ChemInform, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
N. Nakajima, M. Ubukata
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
N. Nakajima, M. Ubukata
openaire +1 more source
The Imide–Amide and Imide–Imide Rearrangements of Imidophosphorus Compounds
Russian Chemical Reviews, 1978Data on the imide?amide and imide?imide rearrangements of imidophosphorous compounds are surveyed, the factors influencing the ease of these rearrangements are noted, and information about their mechanisms is given. The bibliography includes 83 references.
openaire +1 more source
Chemical Communications, 2008
Pyridine-imide oligomers created by incorporating imide and pyridine units alternatively in sequence were successfully synthesized and found to form highly compact and stable helical conformations contributed by intramolecular H-bonds between the imide and both adjacent pyridines, and by the structural characteristics of the imide units.
Xiao, Li +3 more
openaire +2 more sources
Pyridine-imide oligomers created by incorporating imide and pyridine units alternatively in sequence were successfully synthesized and found to form highly compact and stable helical conformations contributed by intramolecular H-bonds between the imide and both adjacent pyridines, and by the structural characteristics of the imide units.
Xiao, Li +3 more
openaire +2 more sources
Current Hematologic Malignancy Reports, 2019
IMiDs are a class of biologic agents with immunomodulatory, anti-angiogenic, and direct anti-cancer activities. This review summarizes current data on clinical development and application of IMiDs in non-Hodgkin lymphoma (NHL) subtypes, focusing primarily on lenalidomide, with additional discussion on managing common side effects.Improved upon the ...
Samuel, Yamshon, Jia, Ruan
openaire +2 more sources
IMiDs are a class of biologic agents with immunomodulatory, anti-angiogenic, and direct anti-cancer activities. This review summarizes current data on clinical development and application of IMiDs in non-Hodgkin lymphoma (NHL) subtypes, focusing primarily on lenalidomide, with additional discussion on managing common side effects.Improved upon the ...
Samuel, Yamshon, Jia, Ruan
openaire +2 more sources
How “immunomodulatory” are IMIDs?
Blood, 2011In this issue of Blood, Hsu and colleagues report that the immunostimulatory effect of lenalidomide on natural killer (NK)–cell function is profoundly suppressed by concurrent dexamethasone (Dex) therapy in multiple myeloma (MM) patients. These results could have major implications for the design of clinical trials combining lenalidomide and ...
openaire +2 more sources
ChemInform Abstract: Imidates Including Cyclic Imidates
ChemInform, 1992AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
openaire +1 more source
Molecular Engineering of Aromatic Imides for Organic Secondary Batteries
Small, 2021Lei Li, Yong Cui
exaly